MMedication Read More More than a third of patients on Wegovy pill are new to GLP-1 drugs, study findsFebruary 11, 2026 By Robin Respaut SAN FRANCISCO, Feb 11 (Reuters) – Among early users of Novo Nordisk’snew Wegovy weight-loss pill,…
HHealthcare Read More What’s the Better Long-Term Investment?February 10, 2026 Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are rivals in the GLP-1 drug market and are…
MMedication Read More Novo Nordisk vows legal action to protect Wegovy pillFebruary 5, 2026 Shares in Novo Nordisk have taken a beating this week after it warned of lower sales revenue in…
MMedication Read More Hims and Hers Health’s compounded Wegovy pill offering fuels market jittersFebruary 5, 2026 Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…
MMedication Read More Hims launches $49 compounded copy of Wegovy weight-loss pillFebruary 5, 2026 By Amina Niasse NEW YORK, Feb 5 (Reuters) – Online telehealth company Hims and Hers Health will start…
MMedication Read More SA sales of weight-loss drugs surge amid global rise in lawsuitsFebruary 5, 2026 Sales of weight-loss drugs are sky-rocketing in South Africa, as it has in other parts of the world.…
HHealthcare Read More Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026February 4, 2026 Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…
HHealthcare Read More Novo Nordisk shares plunge on outlook warning as Mounjaro rival races aheadFebruary 4, 2026 Weight loss drug maker Novo Nordisk has seen shares slump after warning over a sales plunge amid price…
MMedication Read More Novo’s Wegovy pill tracks over 26,000 prescriptionsJanuary 31, 2026 Jan 30 (Reuters) – Novo Nordisk’s Wegovy pill hits over 26,000 U.S. prescriptions in the second full week…
MMedication Read More US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable TherapyJanuary 29, 2026 The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new once-daily pill for weight management, designed…
HHealthcare Read More Roche Shares Rise After Obesity Drug Shows 18% Greater Weight LossJanuary 27, 2026 This article first appeared on GuruFocus. Roche Holding AG (RHHBY) is beginning to show tangible progress in obesity…
MMedication Read More How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?January 26, 2026 Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…